554 related articles for article (PubMed ID: 18189059)
21. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents.
de Leeuw J; van der Beek N; Bjerring P; Neumann HA
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):460-9. PubMed ID: 19796088
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.
Jeffes EW; McCullough JL; Weinstein GD; Kaplan R; Glazer SD; Taylor JR
J Am Acad Dermatol; 2001 Jul; 45(1):96-104. PubMed ID: 11423841
[TBL] [Abstract][Full Text] [Related]
23. Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
Buinauskaite E; Zalinkevicius R; Buinauskiene J; Valiukeviciene S
Photodermatol Photoimmunol Photomed; 2013 Aug; 29(4):173-81. PubMed ID: 23815349
[TBL] [Abstract][Full Text] [Related]
24. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
25. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
26. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
[TBL] [Abstract][Full Text] [Related]
27. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.
Bissonette R; Bergeron A; Liu Y
J Drugs Dermatol; 2004; 3(1 Suppl):S26-31. PubMed ID: 14964758
[TBL] [Abstract][Full Text] [Related]
28. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
Taub AF; Garretson CB
J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
[TBL] [Abstract][Full Text] [Related]
30. Aminolevulinic acid-photodynamic therapy for photorejuvenation.
Nootheti PK; Goldman MP
Dermatol Clin; 2007 Jan; 25(1):35-45. PubMed ID: 17126740
[TBL] [Abstract][Full Text] [Related]
31. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging.
Tierney E; Barker A; Ahdout J; Hanke CW; Moy RL; Kouba DJ
Dermatol Surg; 2009 May; 35(5):725-46. PubMed ID: 19309338
[TBL] [Abstract][Full Text] [Related]
33. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.
Apalla Z; Sotiriou E; Panagiotidou D; Lefaki I; Goussi C; Ioannides D
Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):181-5. PubMed ID: 21729165
[TBL] [Abstract][Full Text] [Related]
34. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
Baptista J; Martinez C; Leite L; Cochito M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light.
Clementoni MT; B-Roscher M; Munavalli GS
Lasers Surg Med; 2010 Feb; 42(2):150-9. PubMed ID: 20166166
[TBL] [Abstract][Full Text] [Related]
37. Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
Babilas P; Travnik R; Werner A; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Jan; 6(1):25-32. PubMed ID: 17995967
[TBL] [Abstract][Full Text] [Related]
38. Topical photodynamic therapy: a new tool in cosmetic dermatology.
Touma DJ; Gilchrest BA
Semin Cutan Med Surg; 2003 Jun; 22(2):124-30. PubMed ID: 12877231
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light.
Yu CH; Lin HP; Chen HM; Yang H; Wang YP; Chiang CP
Lasers Surg Med; 2009 Nov; 41(9):628-33. PubMed ID: 19816916
[TBL] [Abstract][Full Text] [Related]
40. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
